The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1

Journal of Cell Biology

Volumn 142, Issue 3, 1998, Pages 873-881

  Serini, Guido ^a,c   Bochaton Piallat, Marie Luce ^a   Ropraz, Patricia ^a   Geinoz, Antoine ^a   Borsi, Laura ^b   Zardi, Luciano ^b   Gabbiani, Giulio ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

SM actin; Extracellular matrix; Fibroblast; Fibrosis; Wound healing

Indexed keywords

ACTIN; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GRANULATION TISSUE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

ACTINS; ANIMALS; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; FIBRONECTINS; HUMANS; MUSCLE, SMOOTH; PHENOTYPE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0031828004     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.142.3.873     Document Type: Article

References (83)

1. Allen-Hoffmann, B.L., C.L. Crankshaw, and D.F. Mosher. 1988. Transforming growth factor β increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol. Cell. Biol. 8:4234-4242.
2. Balza, E., L. Borsi, G. Allemmanni, and L. Zardi. 1988. Transforming Growth Factor β regulates the levels of different fibronectin isoforms in normal cultured fibroblasts. FEBS (Fed. Eur. Biochem. Soc.) Lett. 228:42-44.
3. Berndt, A., H. Kosmehl, U. Mandel, U. Gabler, X. Luo, D. Celada, L. Zardi, and D. Katenkamp. 1995. TGFβ and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibrosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochemical J. 27:1014-1020.
4. Bochaton-Piallat, M.L., G. Gabbiani, and M.S. Pepper. 1998. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ. Res. 82:1086-1093.
5. Border, W.A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
6. Border, W.A., and N.A. Noble. 1994. Transforming growth factor-β in tissue fibrosis. N. Engl. J. Med. 331:1286-1292.
7. Borsi, L., B. Carnemolla, P. Castellani, C. Rossellini, D. Vecchio, G. Allemmanni, S.E. Chang, J. Taylor-Papadimitriou, H. Pande, and L. Zardi. 1987. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J. Cell Biol. 104:595-600.
8. Borsi, L., P. Castellani, A.M. Risso, A. Leprini, and L. Zardi. 1990. Transforming growth factor β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS (Fed. Eur. Biochem. Soc.) Lett. 261:175-178.
9. Boström, H., K. Willetts, M. Pekny, P. Levéen, P. Lindahl, H. Hedstrand, M. Pekna, M. Hellström, S. Gebre-Medhin, M. Schalling, M. Nilsson, S. Kurland, J. Törnell, J.K. Heath, and C. Betsholtz. 1996. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis Cell. 85:863-873.
10. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72:248-254.
11. Carnemolla, B., L. Borsi, L. Zardi, R.J. Owens, and F.E. Baralle. 1987. Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. Coli. FEBS (Fed. Eur. Biochem. Soc.) Lett. 215:269-273.
12. Carnemolla, B., E. Balza, A. Siri, L. Zardi, M.R. Nicotra, A. Bigotti, and P.G. Natali. 1989. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol. 108:1139-1148.
13. Carnemolla, B., L. Borsi, L. Zardi, R.J. Owens, and F.E. Baralle. 1987. Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. Coli. FEBS (Fed. Eur. Biochem. Soc.) Lett. 215:269-273.
14. Carnemolla, B., A. Leprini, G. Allemanni, M. Saginati, and L. Zardi. 1992. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modification that unmask a cryptic sequence J. Biol. Chem. 267:24689-24692.
15. Chi-Rosso, G., P.J. Gotwals, J. Yang, L. Ling, K. Jiang, B. Chao, D.P. Baker, L.C. Burkly, S.E. Fawell, and V.E. Koteliansky. 1997. Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated β1 integrins. J. Biol. Chem. 272:31447-31452.
16. Cicila, G.T., T.M. O'Connell, W.C. Hahn, and J.G. Rheinwald. 1989. Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing. J. Cell Sci. 94:1-10.
17. Clarke, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science. 268:233-239.
18. Darby, I., O. Skalli, and G. Gabbiani. 1990. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63:21-29.
19. Desmoulière, A., L. Rubbia-Brandt, A. Abdiu, T. Walz, A. Macieira-Coelho, and G. Gabbiani. 1992. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp. Cell Res. 201:64-73.
20. Desmoulière, A., A. Geinoz, F. Gabbiani, and G. Gabbiani. 1993. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122:103-111.
21. Desmoulière, A., and G. Gabbiani. 1996. The role of the myofibroblast in wound healing and fibrocontractive diseases. In The Molecular and Cellular Biology of Wound Repair. R.A.F. Clark, editor. Plenum Press, New York. 391-423.
22. Dugina, V., A. Alexandrova, C. Chaponnier, J. Vasiliev, and G. Gabbiani. 1998. Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp. Cell Res. 238:481-490.
23. Fava, R.A., and D.B. McClure. 1987. Fibronectin-associated transforming growth factor. J. Cell Physiol. 131:184-189.
24. ffrench-Constant, C., L. Van De Water, H.F. Dvorak, and R.O. Hynes. 1989. Reappearance of an embryonic of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 109:903-914.
25. Gabbiani, G., B.J. Hirschel, G.B. Ryan, P.R. Statkov, and G. Majno. 1972. Granulation tissue as contractile organ. A study of structure and function. J. Exp. Med. 135:719-734.
26. Gehris, A.L., E. Stringa, J. Spina, M.E. Desmond, R.S. Tuan, and V.D. Bennett. 1997. The region encoded by the alternatively spliced exon IIIA in mesenchymal fibronectin appears essential for chondrogenesis at the level of cellular condensation. Dev. Biol. 190:191-205.
27. Genovese, C., D. Rowe, and B. Kream. 1984. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry. 23:6210-6216.
28. Giri, S.N., D.M. Hyde, R.K. Braun, W. Gaarde, J.R. Harper, and M.D. Pierschbacher. 1997. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem. Pharmacol. 54:1205-1216.
29. Glukhova, M.A., M.G. Frid, B.V. Shekhonin, T.D. Vasilevskaya, J. Grunwald, M. Saginati, and V.E. Koteliansky. 1989. Expression of extra domain-A fibronectin sequence in vascular smooth muscle cells is phenotype dependent J. Cell Biol. 109:357-366.
30. Glukhova, M.A., M.G. Frid, B.V. Shekhonin, Y.V. Balabanov, and V.E. Koteliansky. 1990. Expression of fibronectin variants in vascular and visceral smooth muscle cells in development. Dev. Biol. 141:193-202.
31. Grinnell, F. 1994. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124:401-404.
32. Hautmann, M.B., C.S. Madsen, and G.K. Owens. 1997. A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J. Biol. Chem. 272:10948-10956.
33. Heldin, C.H., K. Miyazono, and P. ten Dijke. 1997. TGFβ signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:465-471.
34. Humphries, M.J., S.K. Akiyama, A. Komoriya, K. Olden, and K.M. Yamada. 1988. Neurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segment. J. Cell Biol. 106:1289-1297.
35. Hynes, R.O. 1990. Fibronectins. In Springer's Series in Molecular Biology. A. Rich, editor. Springer-Verlag, Inc., New York. 546 pp.
36. Ignotz, R.A., and J. Massagué. 1986. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:4337-4345.
37. Isaka, Y., D.K. Brees, K. Ikegaya, Y. Kaneda, E. Imai, N.A. Noble, and W.A. Border. 1996. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med. 2:418-423.
38. Jarnagin, W.R., D.C. Rockey, V.E Koteliansky, S.S. Wang, and D.M. Bissell. 1994. Expression of variant fibronectin in wound healing: cellular source and biological activity of the EIIIA fibronectin segment in rat hepatic fibrogenesis. J. Cell Biol. 127:2037-2048.
39. Keski-Oja, J., R. Raghow, M. Sawdey, D.J. Loskutoff, A.E. Postlethwaite, A.H. Kang, and H.L. Moses. 1988. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J. Biol. Chem. 263:3111-3115.
40. Kingsley, D.M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133-146.
41. Kocher, O., S.P. Kennedy, and J.A. Madri. 1990. Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Am. J. Pathol. 137:1509-1524.
42. Kornblihtt, A.R., K. Vibe-Pedersen, and F.E. Baralle. 1984. Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res. 12:5853-5868.
43. Kornblihtt, A.R., C.G. Pesce, C.R. Alonso, P. Cramer, A. Srebrow, S. Werbajh, and A.F. Muro. 1996. The fibronectin gene as a model for splicing and transcription studies. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:248-257.
44. Kosmehl, H., A. Berndt, and D. Katenkamp. 1996. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch. 429:311-322.
45. 1 null mutation causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
46. Kurkinen, M., A. Vaheri, P.J. Roberts, and S. Stenman. 1980. Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab. Invest. 43:47-51.
47. Leonard, C.M., H.M. Fuld, D.A. Frenz, S.A. Downie, J. Massague, and S.A. Newman. 1991. Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-β and evidence for endogenous TGF-β-like activity. Dev. Biol. 145:99-109.
48. Lund, L.R., A. Riccio, P.A. Andreasen, L.S. Nielsen, P. Kristensen, M. Laiho, O. Saksela, F. Blasi, and K. Dano. 1987. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO (Eur. Mol. Biol. Organ.) J. 6:1281-1286.
49. MacLeod, J.N., N. Burton-Wurster, D.N. Gu, and G. Lust. 1996. Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15, and I-10protein segments. J. Biol. Chem. 271:18954-18960.
50. Manabe, R., N. Oh-e, T. Maeda, T. Fukuda, and K. Sekiguchi. 1997. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J. Cell Biol. 139:295-307.
51. Mariani, G., A. Lasku, E. Balza, B. Gaggero, C. Motta, L. Di Luca, A. Dorcaratto, G.A. Viale, D. Neri and L. Zardi. 1997a. Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants. Cancer. 80:2378-2384.
52. Mariani, G., A. Lasku, A. Pau, G. Villa, C. Motta, G. Calcagno, G.Z. Taddei, P. Castellani, K. Syrigos, A. Dorcaratto, A.A. Epenetos, L. Zardi and G.A. Viale. 1997b. A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors. Cancer. 80:2484-2489.
53. Marx, J. 1995. DNA repair defect tied to mutated TGF-β receptor gene. Science. 268:1276-1277.
54. Massagué, J., A. Hata, and F. Liu. 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7:187-192.
55. Masur, S.K., H.S. Dewal., T.T. Dinh, I. Erenburg., and S. Petridou. 1996. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. USA. 93:4219-4223.
56. McDonald, J.A. 1994. Extracellular matrix assembly. Methods Enzymol. 245: 518-531.
57. Moyano, J.V., B. Carnemolla, C. Dominguez-Jimenez, M. Garcia-Gila, J.P. Albar, P. Sanchez-Aparicio, A. Leprini, G. Querze, L. Zardi, and A. Garcia-Pardo. 1997. Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated α4β1 and α4β7 integrins. J. Biol. Chem. 272:24832-24836.
58. Neri, D., B. Carnemolla, A. Nissim, A. Leprini, G. Querze, E. Balza, A. Pini, L. Tarli, C. Halin, P. Neri, L. Zardi and G. Winter. 1997. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat. Biotechnol. 15:1271-1275.
59. Penttinen R.P., S. Kobayashi, and P. Bornstein. 1988. Transforming growth factor β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc. Natl. Acad. Sci. USA. 85:1105-1108.
60. + isoforms by human and experimental colorectal cancer. Am. J. Pathol. 148:579-592.
61. Pytela, R., M.D. Pierschbacher, W.S. Argrves, S. Suzuki, and E. Ruoslahti. 1987. Arg-Gly-Asp adhesion receptors. Methods Enzymol. 144:475-189.
62. Roberts, A.B., M.B. Sporn, A.K. Assoian, J.M. Smith, N.S. Roche, L.M. Wakefield, U.I. Heine, L.A. Liotta, V. Falanga, J.H, Kehrl, and A.S. Fauci. 1986. Transforming growth factor type-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA. 83:4167-4171.
63. Roberts, A.B., and M.B. Sporn. 1993. Physiological actions and clinical applications of transforming growth factor β (TGFβ). Growth Factors. 8:1-9.
64. Rønnov-Jessen, L., and O.W. Petersen. 1993. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest. 68:696-707.
65. Rønnov-Jessen, L., O.W. Petersen, and M.J. Bissell. 1996. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76:69-125.
66. Sappino, A.P., W. Schurch, and G. Gabbiani. 1990. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63:144-161.
67. Schlaepfer, D.D., and T. Hunter. 1998. Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol. 8:151-157.
68. Schwartz, M.A. 1997. Integrins, oncogenes, and anchorage independence. J. Cell Biol. 139:575-578.
69. Schürch, W., T.A. Seemayer, and G. Gabbiani. 1992. Myofibroblast. In Histology for Pathologists. S.S. Sternberg, editor. Raven Press, New York. 109-144.
70. Serini, G., and G. Gabbiani. 1996. Modulation of α-smooth muscle actin expression in fibroblasts by transforming growth factor-β isoforms: an in vivo and in vitro study. Wound. Rep. Reg. 4:278-287.
71. Shrivastava, A., C. Radziejewski, E. Campbell, L. Kovac, M. McGlynn, T.E. Ryan, S. Davis, M.P. Goldfarb, D.J. Glass, G. Lemke, and G.D. Yancopoulos. 1997. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell. 1:25-34.
72. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, D.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
73. Skalli, O., P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen, and G. Gabbiani. 1986. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell. Biol. 103:2787-2796.
74. Soriano, P. 1994. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 8:1888-1896.
75. Sporn, M.B., and A.B. Roberts. 1992. Transforming growth factor β: recent progress and new challenges. J. Cell Biol. 119:1017-1021.
76. Streuli, C.H., C. Schmidhauser, M. Kobrin, M.J. Bissel, and R. Derynck. 1993. Extracellular matrix regulates expression of the TGFβ1 gene. J. Cell Biol. 120:253-260.
77. Taipale, J., and J. Keski-Oja. 1997. Growth factors in the extracellular matrix. FASEB (Fed. Am. Soc. Exp. biol.)J. 11:51-59.
78. Vogel, W., G.D. Gish, F. Alves, and T. Pawson. 1997. The discoidin domain receptor tyrosine kinases are activated by collagen. mol. Cell. 1:13-23.
79. Xia, P., and L.A. Culp. 1994. Adhesion activity in fibronectin's alternatively spliced domain ED-A (EIIIA) and its neighboring type III repeats: oncogene-dependent regulation. Exp. Cell Res. 213:253-265.
80. Xu, G., M. Redard, G. Gabbiani, P. Neuville. Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am. J. Pathol. 151: 1741-1749.
81. Zambruno, G., P.C. Marchisio, A. Marconi, C. Vaschieri, A. Melchiori, A. Giannetti, and M. De Luca. 1995. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces de novo expression αvβ6 heterodimer in normal keratinocytes: implication for wound healing. J. Cell Biol. 129:853-865.
82. Zardi, L., A. Siri, B. Carnemolla, E. Cosulich, G. Viale, and L. Santi. 1980. A simplified procedure for the preparation of antibodies to serum fibronectin. J. Immunol. Methods 34:155-165.
83. Zhang, K., M.D. Rekhter, D. Gordon, and S.H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J. Pathol. 145:114-125.